Gambaran Epidemiologi Kasus Tumor Meningioma Intrakranial WHO Derajat II dan III di Rumah Sakit Kanker Dharmais

Arwinder Singh, Muhammad Firdaus, Oskar Ady Widarta, Yosafat Kurniawan Sugiarto, Danny Halim, Ahmad Faried

Sari


ABSTRACT

 

Meningioma is the most common primary intracranial tumors in adults. Although most meningioma cases are regarded as benign, certain types have been suggested of having higher proliferative capacities compared to the majority. Knowing the epidemiology of the more aggressive types of meningioma are important to anticipate the disease burden and improve their management.  This study aims to describe the epidemiology of WHO grade II and III intracranial meningiomas at Dharmais National Cancer Center Hospital. All patients diagnosed with WHO grade II or III intracranial meningiomas between 2011 and 2022 were included in this study. Information on patient’s characteristics, tumor location, and histopathological analyses. As many as thirty-three patients diagnosed with WHO grade II and III intracranial meningiomas between 2011 and 2022. Most patients were female (72.72%), aged between 40- to 60-year-old (57.57%), classified as WHO grade II (60.6%), and had their tumors located at convexity regions (48.48%). The most common grade II intracranial meningioma is atypical (95%), while the majority of grade III intracranial meningiomas is anaplastic (76.92%). In both WHO grade II and III intracranial meningiomas, the highest number of patients aged between 40- to 60-year-old, 60% and 53.85%, respectively. Interestingly, most WHO grade II intracranial meningiomas were in skullbase regions (50%); meanwhile, majority of WHO grade III intracranial meningiomas were in convexity regions (69.23%). Although it only represents a minor fraction from the total meningioma cases, patients who are diagnosed with WHO grade II and III intracranial meningiomas are faced with higher risks of morbidity and mortality compared to WHO grade I intracranial meningiomas. The results of this study describe the current epidemiology of this challenging tumor.

 

Keywords : Intracranial, Meningioma, Benign, WHO Grading

 

ABSTRAK

 

Meningioma adalah tumor intrakranial yang paling sering terjadi pada pasien dewasa. Meskipun kebanyakan kasus meningioma intrakranial tergolong jinak, namun beberapa tipe meningioma tertentu terbukti memiliki kapasitas proliferatif yang lebih tinggi dibandingkan dengan mayoritas tipe meningioma. Pengetahuan mengenai epidemiologi dari tipe meningioma yang bersifat agresif sangatlah penting untung mengetahui beban penyakit dan melakukan upaya peningkatan manajemen penyakit ini. Penelitian ini bertujuan untuk mengetahui data epidemiologi meningioma intrakranial derajat 2 dan 3 berdasarkan klasifikasi histopatologis yang ditetapkan oleh badan kesehatan dunia / World Health Organization (WHO). Seluruh pasien yang didiagnosis dengan meningioma intrakranial derajat 2 dan 3 di RS Kanker Dharmais selama periode tahun 2011 s.d. 2022 dimasukkan ke dalam studi ini. Data mengenai karakteristik pasien, lokasi tumor, dan hasil analisis histopatologis diambil dan diolah sebagai data penelitian. Sebanyak 33 pasien didiagnosis dengan meningioma intrakranial derajat 2 dan 3 selama periode tahun 2011 s.d. 2022. Mayoritas pasien adalah perempuan (72.72%), berusia antara 40 s.d. 60 tahun (57.57%), didiagnosis dengan meningioma intrakranial derajat 2 (60.6%), dengan lokasi tumor di daerah konveksitas (48.48%). Jenis meningioma derajat 2 tersering adalah atipikal (95%), sedangkan jenis meningioma derajat 3 tersering adalah anaplastik (76.92%). Rentang usia terbanyak dari pasien penderita meningioma intrakranial derajat 2 (60%) dan 3 (53.85%) adalah 40 s.d. 60 tahun. Dalam hal lokasi tumor, lokasi tumor tersering dari meningioma derajat 2 adalah dasar tengkorak (50%), sedangkan lokasi tumor tersering dari meningioma derajat 3 adalah konveksitas (69.23%). Meskipun mayoritas pasien yang didiagnosis dengan meningioma intrakranial tergolong sebagai derajat 1, namun pasien meningioma intrakranial derajat 2 dan 3 memiliki resiko morbiditas dan mortalitas yang lebih tinggi. Hasil dari penelitian ini memaparkan data epidemiologi terkini dari jenis meningioma intrakranial yang terbilang lebih agresif.

 

Kata Kunci: Meningioma, Intrakranial, Jinak, Derajat WHO


Teks Lengkap:

Download Artikel

Referensi


Alruwaili, A. A., & De Jesus, O. (2023). Meningioma. In StatPearls. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/31675094

Bachir, S., Shah, S., Shapiro, S., Koehler, A., Mahammedi, A., Samy, R. N., … Sengupta, S. (2021). Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis. International Journal of Molecular Sciences, 22(2), 690. https://doi.org/10.3390/ijms22020690

Cho, M., Joo, J.-D., Kim, I. A., Han, J. H., Oh, C. W., & Kim, C.-Y. (2017). The Role of Adjuvant Treatment in Patients with High-Grade Meningioma. Journal of Korean Neurosurgical Society, 60(5), 527–533. https://doi.org/10.3340/jkns.2016.1111.009

Claus, E. B., Black, P. M., Bondy, M. L., Calvocoressi, L., Schildkraut, J. M., Wiemels, J. L., & Wrensch, M. (2007). Exogenous hormone use and meningioma risk. Cancer, 110(3), 471–476. https://doi.org/10.1002/cncr.22783

Harland, T. A., Freeman, J. L., Davern, M., McCracken, D. J., Celano, E. C., Lillehei, K., … Ormond, D. R. (2018). Progesterone-only contraception is associated with a shorter progression-free survival in premenopausal women with WHO Grade I meningioma. Journal of Neuro-Oncology, 136(2), 327–333. https://doi.org/10.1007/s11060-017-2656-9

Hemmati, S. M., Ghadjar, P., Grün, A., Badakhshi, H., Zschaeck, S., Senger, C., … Kaul, D. (2019). Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma. Radiation Oncology, 14(1), 160. https://doi.org/10.1186/s13014-019-1368-z

Holleczek, B., Zampella, D., Urbschat, S., Sahm, F., von Deimling, A., Oertel, J., & Ketter, R. (2019). Incidence, mortality and outcome of meningiomas: A population-based study from Germany. Cancer Epidemiology, 62, 101562. https://doi.org/10.1016/j.canep.2019.07.001

Hsu, D. W., Efird, J. T., & Hedley-Whyte, E. T. (1997). Progesterone and estrogen receptors in meningiomas: prognostic considerations. Journal of Neurosurgery, 86(1), 113–120. https://doi.org/10.3171/jns.1997.86.1.0113

Kamiguchi, H., Shiobara, R., & Toya, S. (1996). Accidentally detected brain tumors: clinical analysis of a series of 110 patients. Clinical Neurology and Neurosurgery, 98(2), 171–175. https://doi.org/10.1016/0303-8467(96)00016-9

Kshettry, V. R., Ostrom, Q. T., Kruchko, C., Al-Mefty, O., Barnett, G. H., & Barnholtz-Sloan, J. S. (2015). Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States. Neuro-Oncology, 17(8), 1166–1173. https://doi.org/10.1093/neuonc/nov069

Lemée, J.-M., Corniola, M. V., Da Broi, M., Joswig, H., Scheie, D., Schaller, K., … Meling, T. R. (2019). Extent of Resection in Meningioma: Predictive Factors and Clinical Implications. Scientific Reports, 9(1), 5944. https://doi.org/10.1038/s41598-019-42451-z

Magill, S. T., Young, J. S., Chae, R., Aghi, M. K., Theodosopoulos, P. V., & McDermott, M. W. (2018). Relationship between tumor location, size, and WHO grade in meningioma. Neurosurgical Focus, 44(4), E4. https://doi.org/10.3171/2018.1.FOCUS17752

Mubeen, B., Makhdoomi, R., Nayil, K., Rafiq, D., Kirmani, A., Salim, O., … Ramzan, A. (2019). Clinicopathological characteristics of meningiomas: Experience from a tertiary care hospital in the Kashmir Valley. Asian Journal of Neurosurgery, 14(01), 41–46. https://doi.org/10.4103/ajns.AJNS_228_16

Ogasawara, C., Philbrick, B. D., & Adamson, D. C. (2021). Meningioma: A Review of Epidemiology, Pathology, Diagnosis, Treatment, and Future Directions. Biomedicines, 9(3), 319. https://doi.org/10.3390/biomedicines9030319

Riemenschneider, M. J., Perry, A., & Reifenberger, G. (2006). Histological classification and molecular genetics of meningiomas. The Lancet Neurology, 5(12), 1045–1054. https://doi.org/10.1016/S1474-4422(06)70625-1




DOI: https://doi.org/10.33024/mahesa.v3i11.11573

Refbacks

  • Saat ini tidak ada refbacks.


Publisher: Universitas Malahayati Lampung


Creative Commons License
Semua artikel dapat digunakan dibawah lisensi Creative Commons Attribution-ShareAlike 4.0 International License


kostenlose besucherzähler